MCRB (STOCKS)
Seres Therapeutics, Inc.
$4.450000
-0.270000 (-5.72%)
Prev close: $4.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Richard N. Kender
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44.64M
- Employees
- 103
- P/E (TTM)
- -1.97
- P/B (TTM)
- 1.34
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.88M |
| Benefits Costs and Expenses | $7.92M |
| Costs And Expenses | $51.19M |
| Nonoperating Income/Loss | $61.57M |
| Operating Expenses | $85.92M |
| Research and Development | $46.64M |
| Other Operating Expenses | $39.28M |
| Operating Income/Loss | -$84.03M |
| Income/Loss From Continuing Operations After Tax | -$22.46M |
| Income/Loss From Continuing Operations Before Tax | -$6.04M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$22.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.44 |
| Diluted Earnings Per Share | -$2.43 |
| Basic Average Shares | 28,170,975 |
| Diluted Average Shares | 28,226,135 |
| Assets | $101.59M |
| Current Assets | $42.35M |
| Noncurrent Assets | $59.24M |
| Fixed Assets | $5.80M |
| Other Non-current Assets | $53.44M |
| Liabilities | $67.05M |
| Current Liabilities | $20.03M |
| Accounts Payable | $1.19M |
| Wages | $2.23M |
| Other Current Liabilities | $16.62M |
| Noncurrent Liabilities | $47.02M |
| Equity | $34.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $34.53M |
| Liabilities And Equity | $101.59M |
| Net Cash Flow From Operating Activities | -$51.26M |
| Net Cash Flow From Operating Activities, Continuing | -$51.26M |
| Net Cash Flow From Investing Activities | $187.00K |
| Net Cash Flow From Investing Activities, Continuing | $187.00K |
| Net Cash Flow From Financing Activities | $14.86M |
| Net Cash Flow From Financing Activities, Continuing | $14.86M |
| Net Cash Flow | -$36.21M |
| Net Cash Flow, Continuing | -$36.21M |
| Comprehensive Income/Loss | -$22.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.46M |
| Other Comprehensive Income/Loss | $5.70M |